Optimal Anesthetic Methods For Percutaneous Left Atrial Appendage Closure

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031857

Enrollment

Unknown

Registered

2020-04-12

Start date

2020-04-12

Completion date

Unknown

Last updated

2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart disease

Interventions

control group:propofol-sufentanil-cisatracurium-neostigmine

experimental group:propofol-refentanil-rocuronium-sugammadex

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. ASA 2-3 patients 2. Patients who received transcatheter closure of left atrial appendage; 3. Patients undergoing general anesthesia by tracheal intubation.

Exclusion criteria

Exclusion criteria: 1. Objects who refuse to participate; 2. Patients with a history of using psychotropic drugs; 3. Patients with history of liver and kidney diseases; 4. Patients with allergic history of neostigmine or atropine 5. Patients with cognitive impairment; 6. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
the Quality of Recovery;	—

Countries

China

Contacts

Public ContactJingxiang Wu

Department of Anesthesiology of ShangHai Chest Hospital

Wu_jingxiang@shchest.org+86 18019370636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026